Skip to content
Search

Latest Stories

Jaguar Land Rover to stop production at Nitra plant

TATA MOTORS owned Jaguar Land Rover (JLR) said that it will suspend production in Slovakia.

The luxury automaker will suspend production temporarily at its Slovakia-based Nitra plant following the coronavirus (Covid-19) pandemic.


However, JLR, which is owned by the Indian auto giant, said late on Tuesday (17) that some of its limited activities will continue at the Nitra plant.

All of JLR plants in the UK will remain open despite Nitra closure.

The Nitra region has five reported cases of coronavirus, with three in the town itself, according to media reports.

Slovakia has 97 confirmed coronavirus cases, whereas the country has reported no deaths.

The Central European country has declared a state of emergency and has shut borders to those without permanent residency in the country.

Britain’s largest carmaker currently employs around 1,500 people in Nitra, 98 per cent are Slovak nationals and 30 per cent are women.

In 2018, JLR opened its state-of-the-art £1 billion manufacturing facility in Nitra, Slovakia.

The new 300,000sq m facility stands at the forefront of aluminium manufacturing and engineering expertise in Slovakia, with an annual capacity of 150,000 vehicles a year, according to the automaker.

Meanwhile, the auto company said a staff member at one of its British satellite facilities, a small site which is not one of the firm's manufacturing locations, has tested positive for coronavirus and is in self-isolation.

"We have informed anyone who has been in close contact with them at work and told them also to self-isolate for 14 days," the company said in a statement.

JLR plans to keep making vehicles at its domestic factories until at least the end of the week despite the impact from coronavirus, which has shut many other car plants.

"All of our UK plants remain open, and we plan to keep building cars until at least the end of the week subject to the ongoing supply of parts," it said in a statement.

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less